Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma
Phase 1
25
about 6 years
18+
1 site in MD
What this study is about
This trial is testing the safety of intraoperative radiation therapy (IORT) after stereotactic body radiation therapy (SBRT) and chemotherapy for people with pancreatic cancer who are having surgery. The treatment involves using a high dose rate brachytherapy technique during surgery.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Acute post-operative toxicity of targeted IORT
Secondary: Late post-operative toxicity of targeted IORT, Median local-progression free survival (LPFS) from IORT, Median overall survival (OS) from IORT, Median progression free survival (PFS) from IORT
radiation
Oncology